EcoDrugPlus

Insulin Receptor

Ensembl ID : ENSAMXG00000001680
Gene Symbol: LOC103039445
3 Cross references
231 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSAMXG00000016228
Gene Symbol: INSRB
1 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSAMXG00000021415
Gene Symbol: LOC103045439
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSAMXG00000020664
Gene Symbol: LOC103037538
3 Cross references
206 Possible Orthologues:

Integrin Alpha-Iib

Ensembl ID : ENSAMXG00000035831
Gene Symbol: LOC103045206
3 Cross references
191 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSAMXG00000001361
Gene Symbol: ITGB3B
1 Cross references
195 Possible Orthologues:

Integrin Beta-1-B-Like

Ensembl ID : ENSAMXG00000012901
Gene Symbol: LOC103041955
2 Cross references
130 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSAMXG00000035720
Gene Symbol: LOC103030260
3 Cross references
221 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSAMXG00000015136
Gene Symbol: LOC103043996
3 Cross references
204 Possible Orthologues:

Integrin Beta-7

Ensembl ID : ENSAMXG00000001590
Gene Symbol: LOC103047301
2 Cross references
149 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSAMXG00000014947
Gene Symbol: ITGA4
1 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSAMXG00000016623
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).